CNS Pharmaceuticals holds virtual analyst and investor day; presentation content not detailed in filing excerpt

CNS Pharmaceuticals, Inc.

Virtual analyst and investor day held on December 11, 2024.
Presentation furnished as Exhibit 99.1 was reviewed at the meeting.
No financial results, guidance, or material updates disclosed in the provided exhibit excerpt.
Filing under Item 7.01 Regulation FD; presentation not filed for Exchange Act purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.